Opendata, web and dolomites

GlucoTab

A Novel ICT Assistant Solution for de-Risked Management of Insulin Dosing and Blood Glucose Levels in Hospitalized Patients with Type 2 Diabetes

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 GlucoTab project word cloud

Explore the words cloud of the GlucoTab project. It provides you a very rough idea of what is the project "GlucoTab" about.

combining    wards    becomes    insulin    complicated    ict    conceived    wrong    prescription    rising    hospital    charts    incidence    lack    enrolling    beds    care    flow    42    guidance    calculations    despite    easing    600    suitable    glucotab    day    assist    extremely    hyperglycemia    decisions    bedside    device    regimen    secretion    days    dosing    least    basal    incorrect    hospitals    patient    diabetic    guidelines    healthcare    standardize    physiological    glucose    turn    50    revenues    rely    hazardous    integration    adaptable    efficient    hypoglycemia    suffer    software    bolus    responsible    13    arduous    error    saturated    diabetes    reducing    medical    medication    encloses    therapy    full    impacted    cumulative    alarming    created    disease    believe    admissions    paper    ups    recommend    follow    incurred    risk    stay    patients    decision    solution    mimic    multiple    risks       treatment    clinical    flexible    judgment    persistent    blood    workload    adjustments    overwhelming    errors    daily    inefficient    launch    precise    market    centric    automate   

Project "GlucoTab" data sheet

The following table provides information about the project.

Coordinator
DECIDE CLINICAL SOFTWARE GMBH 

Organization address
address: NEUE STIFTINGTALSTRASSE 2
city: GRAZ
postcode: 8010
website: n.a.

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Austria [AT]
 Project website http://www.glucotab.at
 Total cost 71˙429 €
 EC max contribution 50˙000 € (70%)
 Programme 1. H2020-EU.2.1.1. (INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies - Information and Communication Technologies (ICT))
2. H2020-EU.2.3.1. (Mainstreaming SME support, especially through a dedicated instrument)
 Code Call H2020-SMEINST-1-2016-2017
 Funding Scheme SME-1
 Starting year 2016
 Duration (year-month-day) from 2016-11-01   to  2017-02-28

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    DECIDE CLINICAL SOFTWARE GMBH AT (GRAZ) coordinator 50˙000.00

Map

 Project objective

'Despite being responsible for up to 1/3 of admissions, the management of type 2 diabetes in hospital wards is still extremely challenging. European clinical guidelines recommend prescription of 'basal-bolus insulin therapy' as it is the most flexible, adaptable and precise regimen available to mimic the physiological secretion of insulin. However, it requires a patient-centric approach with multiple daily follow-ups. Since both persistent hypoglycemia (due to incorrect medication) and hyperglycemia (due to disease) are hazardous, diabetic care requires day-to-day decisions combining medical judgment and clinical findings. This overwhelming task is even more complicated due to the current inefficient methods that rely on by-hand calculations and paper-based charts. Thus, management becomes a complex task, increasing the workload for the already saturated personnel. Most importantly, it increases the overall risk of medical errors. Indeed, 42% in-hospital days are impacted by treatment errors, wrong blood glucose measurements or lack of adjustments on insulin dosing. Thus, 50% of patients suffer at least one medication error during their stay. In response, we have created GlucoTab, an ICT-based software able to assist on the arduous decision-making process daily incurred in the management of type 2 diabetes. GlucoTab will automate and standardize task management, reducing risks, costs and easing the personnel's work-flow. Conceived as a medical device, our product is able to offer guidance on the most suitable insulin dosing regimen for a patient. By enabling the full integration of the patient's bedside management with the general hospital information system, we believe that GlucoTab encloses a cost-efficient solution that will allow hospitals and healthcare systems to face the alarming rising incidence of diabetes. In turn, GlucoTab will provide us estimated cumulative revenues of €7.7 M after enrolling 13,600 beds within five years from market launch.'

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "GLUCOTAB" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "GLUCOTAB" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.2.1.1.;H2020-EU.2.3.1.)

WIMUACT (2017)

TECHNOLOGY FOR THE IMPROVEMENT OF SPORTS PERFORMANCE IN NON-PROFESSIONAL CONTEXTS

Read More  

Enterprise BIM (2017)

Enterprise BIM digitization platform feasibility verification

Read More  

Assist (2015)

Telocate ASSIST – Development and marketing of an acoustic solution for localization and navigation of people in buildings using the smartphone

Read More